Press Releases Filter Filter Results Year 2024 (4) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) October 15, 2020 Abiomed to Host a Virtual Meeting to Discuss New Clinical Data Presented at TCT Connect October 15, 2020 Largest Study of Hemodynamically Supported High-Risk PCI Patients Finds More Complete Revascularization with Impella Leads to Improved Outcomes October 14, 2020 Restore EF Study Demonstrates Impella-Supported High-Risk PCI Improves Left Ventricular Ejection Fraction October 8, 2020 TCT Connect to Highlight How Impella Enables Improved Outcomes for High-Risk PCI, Cardiogenic Shock and Right Heart Failure Patients October 8, 2020 Abiomed Second Quarter Fiscal 2021 Earnings and Conference Call Notification September 14, 2020 Abiomed to Hold Fireside Chat at the Raymond James North American Equities Conference September 8, 2020 Abiomed to Hold Fireside Chat at the 18th Annual Morgan Stanley Global Healthcare Conference August 6, 2020 Abiomed Announces Q1 FY 2021 Revenue of $165 Million and 21% Operating Margin August 4, 2020 FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 Patients July 30, 2020 Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump July 16, 2020 Abiomed First Quarter Fiscal 2021 Earnings and Conference Call Notification July 16, 2020 FDA Approves Data Streaming from the Impella Console, Setting the Stage for Artificial Intelligence Algorithms to Further Improve Patient Outcomes July 1, 2020 Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist June 16, 2020 Abiomed Launches Virtual Physician Education Program, CAMP PCI, to Improve High-Risk PCI Patient Outcomes June 15, 2020 Abiomed Appoints New Chief Medical Officer Charles Simonton, M.D. … 4 5 6 7 …
